These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3766570)

  • 1. Computer program for comparing total costs of intravenous antibiotic regimens.
    Parr MD; Hansen LA; Waite WW; Rapp RP
    Am J Hosp Pharm; 1986 Sep; 43(9):2189-93. PubMed ID: 3766570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of individualizing aminoglycoside dosage regimens.
    Bootman JL; Zaske DE; Wertheimer AI; Rowland C
    Am J Hosp Pharm; 1979 Mar; 36(3):368-70. PubMed ID: 420232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost comparison of intravenous antibiotic administration.
    Plumridge RJ
    Med J Aust; 1990 Nov; 153(9):516-8. PubMed ID: 2233472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomic comparison of sequential IV/oral ciprofloxacin versus ceftazidime in the treatment of nosocomial pneumonia.
    Paladino JA
    Can J Hosp Pharm; 1995 Oct; 48(5):276-83. PubMed ID: 10152782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of a home intravenous antibiotic program.
    Chamberlain TM; Lehman ME; Groh MJ; Munroe WP; Reinders TP
    Am J Hosp Pharm; 1988 Nov; 45(11):2341-5. PubMed ID: 3228090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomics of intravenous antibiotic use in serious infection.
    Levett PN; Jennings AM; Manning KS; Harewood HC; Griffith CR; Williams CJ; Estwick D; Lashley BA
    West Indian Med J; 1995 Sep; 44(3):81-4. PubMed ID: 8560883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-assisted antimicrobial-use monitoring.
    Inaraja MT; Paloma JM; Giráldez J; Idoate AJ; Hualde S
    Am J Hosp Pharm; 1986 Mar; 43(3):664-70. PubMed ID: 3754692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personnel costs and preparation time in a centralized intravenous admixture program.
    Ryan DM; Daniels CE; Somani SM
    Am J Hosp Pharm; 1986 May; 43(5):1222-5. PubMed ID: 3087164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit analysis of an aminoglycoside monitoring service.
    Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
    Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of mixing clindamycin and aminoglycosides.
    Abel SR; Olson SM
    Am J Hosp Pharm; 1987 Jun; 44(6):1385-7. PubMed ID: 3618617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic cost control measures in a hospital pharmacy.
    Manzo J; Amodio-Groton MA; Kleinmann K
    Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Direct cost of antibiotic therapy prescribed for nosocomial bacteremia. Prospective study during 6 months at a CHU (University Hospital Center)].
    Daumal F; Etienne C; Votte P; Bou P; Canarelli B; Desablens F; Schmit JL; Eb F
    Pathol Biol (Paris); 1998 Jun; 46(6):470-5. PubMed ID: 9769884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside use monitored by clinical pharmaceutical services.
    Barriere SL; Conte JE
    Am J Hosp Pharm; 1979 Sep; 36(9):1209-11. PubMed ID: 495621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community].
    Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA
    Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost comparison of two antimicrobial regimens for treating mixed aerobic-anaerobic infections.
    Scheife RT; Tally FP; McGowan K; Gorbach SL
    Am J Hosp Pharm; 1981 Oct; 38(10):1466-9. PubMed ID: 7294038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis.
    Briceland LL; Quintiliani R; Nightingale CH
    Am J Hosp Pharm; 1988 Jan; 45(1):122-5. PubMed ID: 3348224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjusting dosage intervals of intermittent intravenous ranitidine according to creatinine clearance: a cost-minimization analysis.
    Connelly JF
    Hosp Pharm; 1994 Nov; 29(11):992, 996-8, 1001. PubMed ID: 10138581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.
    Bailey TC; Ritchie DJ; McMullin ST; Kahn M; Reichley RM; Casabar E; Shannon W; Dunagan WC
    Pharmacotherapy; 1997; 17(2):277-81. PubMed ID: 9085319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.